Much of our interface with AI now favors ease: auto-suggested content, one-click summaries, and frictionless flows. But this ...

AbbVie is strutting into 2025 like it owns the lab, thanks to a performance cocktail of smart acquisitions, clinical wins, ...

Let’s dig into the relative performance of AbbVie (NYSE:ABBV) and its peers as we unravel the now-completed Q1 therapeutics ...

AbbVie Inc. (ABBV), headquartered in North Chicago, Illinois, is a biopharmaceutical company discovers, develops, ...

Nike has made significant changes at the top of its organization, dividing its Consumer, Product and Brand leadership into 3 ...

Dell vice presidents will now have at least 15 direct reports, while directors and senior managers will have 20.

Analysts raise AbbVie price targets after strong Q1 results, driven by Skyrizi, Rinvoq growth and strategic moves in Parkinson's disease treatments.

The Revenue for Abbvie (ABBV) helps us define sales trends over time. Revenues are the primary indicator of the sales that are generated by a specific company given the general business activities of ...

The results of the incentives created by this tax structure were quite apparent ... As Senator Wyden and his team have highlighted, AbbVie systematically transfers nearly all the profits on ...

North Chicago, Ill.: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE) for the treatment of ...

As Scott mentioned earlier, clearly, obviously, tax has an influence on longer term, how you'd want to structure ... Now AbbVie has a large government affairs organization that engages with ...

Rob Stothard / Bloomberg via Getty Images AbbVie's first-quarter sales and adjusted earnings per share topped estimates. The drugmaker lifted its full-year adjusted EPS forecast by 10 cents.